Rein Therapeutics, Inc. Increase (Decrease) in Other Operating Assets
Rein Therapeutics, Inc. (RNTX) reported Increase (Decrease) in Other Operating Assets of $1.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-14
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $705.00K, a 55.38% decline year-over-year.
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $1.00M, a 31.28% increase year-over-year.
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $0.00.
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$2.34M.
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2025 was $0.00.
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$2.19M, a 73133.33% decline from fiscal 2023.
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2023 was $3.00K.
- Rein Therapeutics, Inc. increase (decrease) in other operating assets for fiscal 2021 was $24.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $705.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.71M 10-Q · filed 2026-08-14 | $1.71M derived: sum of 3 quarters · filed 2026-08-14 | -$636.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.00M 10-Q · filed 2026-05-15 | $1.00M derived: sum of 2 quarters · filed 2026-05-15 | -$1.34M derived: sum of 3 quarters · filed 2026-05-15 | $239.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$2.34M derived: sum of 2 quarters · filed 2026-03-26 | -$764.00K derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-26 |
| 2025-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$764.00K derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.34M 10-Q · filed 2026-08-14 | $2.34M derived: sum of 3 quarters · filed 2026-08-14 | $1.64M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $764.00K 10-Q · filed 2026-05-15 | $764.00K derived: sum of 2 quarters · filed 2026-05-15 | $57.00K derived: sum of 3 quarters · filed 2026-05-15 | -$126.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$707.00K derived: sum of 2 quarters · filed 2026-03-26 | -$890.00K derived: sum of 3 quarters · filed 2026-03-26 | -$2.19M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$707.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$890.00K derived: sum of 2 quarters · filed 2025-11-14 | -$2.19M 10-Q · filed 2025-11-14 | -$2.16M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.48M 10-Q · filed 2025-08-14 | -$1.46M derived: sum of 3 quarters · filed 2025-08-14 | -$1.46M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$1.30M 10-Q · filed 2025-05-15 | -$1.27M derived: sum of 2 quarters · filed 2025-05-15 | -$1.27M derived: sum of 3 quarters · filed 2025-05-15 | -$1.27M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $27.00K derived: sum of 2 quarters · filed 2025-04-07 | $27.00K derived: sum of 3 quarters · filed 2025-04-07 | $3.00K 10-K · filed 2025-04-07 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | -$24.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$24.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$24.00K 10-Q · filed 2024-05-15 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $0.00 derived: sum of 2 quarters · filed 2023-03-20 | $2.00K derived: sum of 3 quarters · filed 2023-03-20 | $24.00K 10-K · filed 2023-03-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $2.00K derived: sum of 2 quarters · filed 2022-11-01 | $24.00K 10-Q · filed 2022-11-01 | -$5.53M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $24.00K 10-Q · filed 2022-08-15 | -$5.53M derived: sum of 3 quarters · filed 2022-08-15 | -$5.70M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-05 | -$5.53M derived: sum of 2 quarters · filed 2022-05-05 | -$5.70M derived: sum of 3 quarters · filed 2022-05-05 | -$5.87M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$5.72M derived: sum of 2 quarters · filed 2022-03-28 | -$5.89M derived: sum of 3 quarters · filed 2022-03-28 | -$6.06M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$173.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$343.00K derived: sum of 2 quarters · filed 2021-11-12 | -$510.00K 10-Q · filed 2021-11-12 | -$976.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$337.00K 10-Q · filed 2021-08-11 | -$803.00K derived: sum of 3 quarters · filed 2021-08-11 | -$964.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$167.00K 10-Q · filed 2021-05-11 | -$633.00K derived: sum of 2 quarters · filed 2021-05-11 | -$794.00K derived: sum of 3 quarters · filed 2021-05-11 | -$952.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$627.00K derived: sum of 2 quarters · filed 2021-03-24 | -$785.00K derived: sum of 3 quarters · filed 2021-03-24 | -$1.32M 10-K · filed 2021-03-24 |
| 2019-09-30 | -$161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$319.00K derived: sum of 2 quarters · filed 2020-11-12 | -$852.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$691.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | -$533.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | -$15.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |